1. Home
  2. PHGE vs AWX Comparison

PHGE vs AWX Comparison

Compare PHGE & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • AWX
  • Stock Information
  • Founded
  • PHGE 2015
  • AWX 1998
  • Country
  • PHGE Israel
  • AWX United States
  • Employees
  • PHGE N/A
  • AWX N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • AWX Environmental Services
  • Sector
  • PHGE Health Care
  • AWX Utilities
  • Exchange
  • PHGE Nasdaq
  • AWX Nasdaq
  • Market Cap
  • PHGE 13.3M
  • AWX 13.6M
  • IPO Year
  • PHGE N/A
  • AWX 1998
  • Fundamental
  • Price
  • PHGE $0.60
  • AWX $3.11
  • Analyst Decision
  • PHGE Strong Buy
  • AWX
  • Analyst Count
  • PHGE 2
  • AWX 0
  • Target Price
  • PHGE $13.50
  • AWX N/A
  • AVG Volume (30 Days)
  • PHGE 126.6K
  • AWX 14.2K
  • Earning Date
  • PHGE 04-02-2025
  • AWX 03-20-2025
  • Dividend Yield
  • PHGE N/A
  • AWX N/A
  • EPS Growth
  • PHGE N/A
  • AWX N/A
  • EPS
  • PHGE N/A
  • AWX 0.25
  • Revenue
  • PHGE N/A
  • AWX $83,487,000.00
  • Revenue This Year
  • PHGE N/A
  • AWX N/A
  • Revenue Next Year
  • PHGE N/A
  • AWX N/A
  • P/E Ratio
  • PHGE N/A
  • AWX $12.32
  • Revenue Growth
  • PHGE N/A
  • AWX N/A
  • 52 Week Low
  • PHGE $0.48
  • AWX $2.00
  • 52 Week High
  • PHGE $6.30
  • AWX $3.99
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 35.68
  • AWX 41.75
  • Support Level
  • PHGE $0.60
  • AWX $3.20
  • Resistance Level
  • PHGE $0.69
  • AWX $3.42
  • Average True Range (ATR)
  • PHGE 0.11
  • AWX 0.19
  • MACD
  • PHGE -0.04
  • AWX -0.02
  • Stochastic Oscillator
  • PHGE 3.10
  • AWX 15.28

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

Share on Social Networks: